• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Population Outcomes and Return on Value With CGMs

Opinion
Video

Experts discuss the metrics used to evaluate continuous glucose monitoring (CGM)'s comprehensive return on investment, including both cost savings and quality measure performance, and identify which patient populations demonstrate the strongest combined benefits in costs, quality measures, and outcomes, along with how these groups are prioritized for CGM access.

Related Videos
5 experts are featured in this series
5 experts are featured in this series
Nini Wu, MD, Navista
Dr Emma Achola-Kothari
1 expert in this video
1 expert in this video
4 experts are featured in this series.
5 experts in this video
4 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.